ERCC1 as a predictor of response to induction therapy for stage III non-small cell lung cancer.

被引：0
|
作者：
Marra, Alessandro
Kemming, Dirk
Krueer, Thomas
Bosse, Ulrich
Netchaeva, Maria
Wagner, Wolfgang
Koch, Olaf M.
Vogt, Ulf
Hillejan, Ludger
机构：
[1] Niels Stensen Clin, Lung Ctr, Ostercappeln, Germany
[2] European Lab Assoc, Ibbenburen, Germany
[3] Inst Pathol Osnabruck, Osnabruck, Germany
[4] Klinikum Osnabruck, Osnabruck, Germany
[5] Paracelsus Klin, Dept Radiooncol, Osnabruck, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e18511
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HER-2/NEU and ERCC1 in advanced non-small cell lung cancer
    Yoo, J.
    HISTOPATHOLOGY, 2010, 57 : 220 - 220
  • [32] Multimodality therapy in stage III non-small cell lung cancer
    Edelman, MJ
    Gandara, DR
    Roach, M
    Benfield, JR
    ANNALS OF THORACIC SURGERY, 1996, 61 (05): : 1564 - 1572
  • [33] Non-small cell lung cancers:: ERCC1, a therapeutic biomarker in view
    Benard, Jean
    BULLETIN DU CANCER, 2006, 93 (11) : 1086 - 1086
  • [34] Expression of ERCC1 and class III β-tubulin is associated with the survival of resected stage III non-small cell lung cancer patients treated with induction chemoradiotherapy using carboplatin-taxane
    Huang, Cheng-Long
    Kadota, Kyuichi
    Liu, Dage
    Ueno, Masaki
    Nakasima, Nariyasu
    Ishikawa, Shinya
    Gotoh, Masashi
    Misaki, Noriyuki
    Chang, Sung-Soo
    Yokomise, Hiroyasu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2010, 1 (03) : 445 - 451
  • [35] Induction treatment in patients with stage III non-small cell lung cancer
    Palmero, Ramon
    Vilarino, Noelia
    Navarro-Martin, Arturo
    Nadal, Ernest
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (01) : 539 - 554
  • [36] A Quantitative Assay of ERCC1 Expression in Circulating Tumor Cells (CTCs) in Non-small Cell Lung Cancer (NSCLC): A Potential Predictor of Treatment Response
    Das, M.
    Hsieh, B. H.
    Krivacic, R. T.
    Lazarus, N.
    Bennis, R.
    Ly, J.
    Schwartz, E.
    Zhou, L.
    Bruce, R. H.
    Wakelee, H. A.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S535 - S535
  • [37] ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III-IV non-small cell lung cancer
    Kolesnik, O. P.
    Kuzmenko, V. O.
    PATHOLOGIA, 2020, (01): : 15 - 20
  • [38] FDG uptake as a predictor of outcome in stage I non-small cell lung cancer.
    Viswanathan, A. K.
    Pillot, G.
    Goodgame, B.
    Yang, Z.
    Shriki, J.
    Gao, F.
    Dehdashti, F.
    Siegel, B. A.
    Govindan, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 420S - 420S
  • [39] ERCC1 expression of small cell lung cancer
    Hennemann, Marluce
    Sostruznik, Maria H.
    Gaiger, Ana
    Barrios, Carlos H.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S807 - S807
  • [40] Stage III Non-small Cell Lung Cancer
    Rusch, Valerie W.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 37 (05) : 727 - 735
12345